Divi's Laboratories
Signals mentioning Divi's Laboratories
- Forthcoming book profiles Titan’s crisis-to-growth playbook
- Voltas posts 45% secondary-volume growth, plans RAC compressor JV with Atomberg
- Macquarie retains Titan as a ‘Star’; adds Phoenix Mills to ‘Rising Stars’
- HDFC Securities retains Reduce on Dixon, raises target price to Rs 12,660
- Choice Broking tags MedPlus a breakout buy at ₹889.60, eyes ₹965 target